Your browser doesn't support javascript.
loading
Analysis of the Safety of Pegfilgrastim Addition in Bleomycin, Etoposide, and Cisplatin Treatment Patients With Germ Cell Tumors.
Nakagawa, Ryunosuke; Iwamoto, Hiroaki; Makino, Tomoyuki; Kadomoto, Suguru; Yaegashi, Hiroshi; Iijima, Masashi; Kawaguchi, Shohei; Nohara, Takahiro; Shigehara, Kazuyoshi; Izumi, Kouji; Kadono, Yoshifumi; Mizokami, Atsushi.
Afiliação
  • Nakagawa R; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Iwamoto H; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Makino T; Department of Urology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan.
  • Kadomoto S; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Yaegashi H; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Iijima M; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Kawaguchi S; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Nohara T; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Shigehara K; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Izumi K; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Kadono Y; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Mizokami A; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
Front Oncol ; 11: 770067, 2021.
Article em En | MEDLINE | ID: mdl-35070973

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article